Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
Polymyosytis; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 62-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (manufacturer Unknown , Dose1), for Covid-19 Immunization. The following information was reported: POLYMYOSITIS (medically significant), outcome "unknown", described as "Polymyosytis". The patient was diagnosed with POLYMYOSYTIS that could have been induced by the Pfizer COVID vaccine that was administered to him 2-3 years ago. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.